<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02919423</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00077293</org_study_id>
    <nct_id>NCT02919423</nct_id>
  </id_info>
  <brief_title>TMS Modulation of Insula-related Brain Networks.02</brief_title>
  <acronym>TMSINS02</acronym>
  <official_title>TMS Modulation of Insula-related Brain Networks.02</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the modulatory effects of repetitive transcranial
      magnetic stimulation (rTMS) on functional connectivity with the insula. Functional
      connectivity (FC) measures the interaction between brain regions, and recent neuroimaging
      studies have used FC to investigate how addiction affects FC among pertinent brain regions.
      rTMS, which can excite cortical neurons, has shown promise as a method to manipulate brain
      connectivity and could be used therapeutically to treat addiction. However, investigators
      first need more information on brain FC and how it relates to behavior, in order to guide
      rTMS target selection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Actual">January 25, 2018</completion_date>
  <primary_completion_date type="Actual">January 25, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in functional connectivity strength measured with functional magnetic resonance imaging</measure>
    <time_frame>baseline and 1 week</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>active TMS nonsmokers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active TMS will be administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>active TMS smokers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active TMS will be administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham TMS nonsmokers</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham TMS will be administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham TMS smokers</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham TMS will be administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial magenetic stimulation</intervention_name>
    <arm_group_label>active TMS nonsmokers</arm_group_label>
    <arm_group_label>active TMS smokers</arm_group_label>
    <arm_group_label>sham TMS nonsmokers</arm_group_label>
    <arm_group_label>sham TMS smokers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  generally healthy

          -  between the ages of 18-55

          -  right-handed

        Exclusion Criteria:

          -  significant health problems (e.g., current and uncontrolled liver, lung, or heart
             problems) or presence of medical illness likely to alter brain morphology (including
             history of seizure, history of epilepsy in self or first degree relatives, stroke,
             brain surgery, head injury, and known structural brain lesion)

          -  current diagnosis of Axis I psychiatric disorders (e.g., depression, anxiety disorder,
             schizophrenia)

          -  meet DSM-5 criteria for current substance use disorder other than nicotine

          -  use of psychoactive medications that would result in a positive urine drug screen

          -  Current use of medications known to lower the seizure threshold

          -  positive breath alcohol concentration

          -  presence of conditions that would make MRI unsafe (e.g., metal implants, pacemakers)

          -  among women, a positive urine pregnancy test

          -  vision that cannot be corrected to 20/40
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merideth Addicott, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>September 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2016</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

